Both in Pharmaceuticals
Arcturus Therapeutics Holdings vs Canopy Growth
Over the past year ARCT returned −27.1% and CGC returned −41.1%; their daily moves had a correlation of 0.16.
ARCT −27.1% CGC −41.1%Growth of $1, one year, split-adjusted
| Metric | ARCT | CGC |
|---|---|---|
| Price | $13.70 | $0.9251 |
| Market cap | $389.4M | $391.4M |
| Today | −5.26% | −0.03% |
| 1 month | −9.8% | −7.4% |
| 6 months | +98.6% | +8.0% |
| Year to date | +123.5% | −18.9% |
| 1 year | −38.2% | −31.0% |
| Revenue growth (YoY) | −89.5% | +7.8% |
| Gross margin | 100.0% | 27.4% |
| Net margin | −803.8% | −18.0% |
| P/E (TTM) | — | — |
| Price / sales | 13.3× | 1.6× |
| Net cash | $191.5M | $67.9M |
| Dividend yield | — | — |
| Volatility (60d) | 99.0% | 33.1% |
| Short % of float | 24.0% | 6.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).